Affymetrix (AFFX) does not have an anemia drug candidate in their pipeline. Affymetrix (AFFX) is a life sciences tools company and not a drug company. They ARE NOT trying to market an anemia drug.
This is the inaccurracy from the Reuters article: "There was a time when products got full value prior to launch. I think we have now swung back in the other direction," said John Orwin, chief executive officer at Affymax Inc (AFFX.O), which expects U.S. regulators to decide by late March whether to approve its experimental anemia drug."
The article names the correct company with the anemia drug candidate, but assigned it the wrong ticker symbol. The ticker symbol for Affymax is (AFFY) Affymax and Affymetrix are not excusively linked. Affymax (AFFY) is the company which is trying to develop and market an anemia drug, NOT AFFYMETRIX (AFFX).